|1.||Peacock, Linda: 1 article (08/2004)|
|2.||Malik, Peter: 1 article (08/2004)|
|3.||Andersen, Maibritt B: 1 article (08/2004)|
|1.||Movement Disorders (Movement Disorder)
08/01/2004 - "Eight Cebus monkeys displaying mild to severe TD due to previous chronic exposure to DA D2 antagonists were acutely injected with SKF 81297 (DA D1 agonist) 0.3 and 0.6 mg/kg, pramipexole (DA D3>D2 agonist) 0.025-0.1 mg/kg, CIS-8-OH-PBZI (DA D3 agonist) 5-10 mg/kg and SB-27701-A (DA D3 antagonist) 1-5 mg/kg and rated for oral dyskinesia. "